Antibiotics Management icon

1.0.5 by ETOS Way


Oct 21, 2024

About Antibiotics Management

Antibiotic choices for common infections.

The following information is a consensus guide. It is intended to aid selection of an

appropriate antibiotic for typical patients with infections commonly seen in general

practice. Individual patient circumstances and local resistance patterns may alter

treatment choices.

it contain following topics

>>Respiratory

COPD – acute exacerbations

Pertussis (whooping cough)

Pneumonia – adult

Pneumonia – child

>>Genito urinary

Bacterial vaginosis

Chlamydia

Epididymo-orchitis

Gonorrhoea

Pelvic inflammatory disease

Trichomoniasis

Urethritis – acute non-specific, male

Urinary Tract Infection Cystitis adult

Urinary Tract Infection Pyelonephritis

Urinary tract infection Cystitis child

>>Skin

Bites – human and animal

Boils (furuncles)

Cellulitis 1

Diabetic foot infections

Impetigo

Mastitis

>>Gastrointestinal

Campylobacter enterocolitis

Clostridium difficilecolitis

Giardiasis

Salmonella enterocolitis

>>Ear, nose and throat

Otitis externa – acute

Otitis media – acute

Pharyngitis

Sinusitis – acute

>>Eyes

Cellulitis

Conjunctivitis

>>CNS

Meningitis and meningococcal septicaemia

What's New in the Latest Version 1.0.5

Last updated on Oct 21, 2024

We
*Removed crashes and bugs
*Re designed UI & UX
*This is 1.0.5 version

Translation Loading...

Additional APP Information

Latest Version

Request Antibiotics Management Update 1.0.5

Uploaded by

Thiago Moura

Requires Android

Android 5.0+

Available on

Get Antibiotics Management on Google Play

Show More

Antibiotics Management Screenshots

Comment Loading...
Searching...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.